Comments
Loading...
Exact Sciences (EXAS) Forecast
NewsEarningsExact Sciences (EXAS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestExact Sciences (NASDAQ:EXAS) Stock Quotes, Forecast and News Summary
Exact Sciences Stock (NASDAQ: EXAS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exact Sciences (EXAS) stock?
You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.
Who are Exact Sciences (EXAS) competitors?
Other companies in Exact Sciences’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).
What is the forecast, or price target, for Exact Sciences (EXAS) stock?
Exact Sciences has a consensus price target of $75.13.
What is the current price for Exact Sciences (EXAS)?
The stock price for Exact Sciences (NASDAQ: EXAS) is $53.955 last updated November 21, 2024 at 12:54 PM EST.
Does Exact Sciences (EXAS) pay a dividend?
There are no upcoming dividends for Exact Sciences.
When is Exact Sciences (NASDAQ:EXAS) reporting earnings?
Exact Sciences’s Q4 earnings are confirmed for Wednesday, February 19, 2025.
Is Exact Sciences (EXAS) going to split?
There is no upcoming split for Exact Sciences.
What sector and industry does Exact Sciences (EXAS) operate in?
Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.